• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Sable Bio

To add a bio or update company history click update information.

News from Sable Bio

    Sable Bio secures a £2.7m seed round led by MMC Ventures to improve drug safety assessment for pharma firmsSable Bio secures a £2.7m seed round led by MMC Ventures to improve drug safety assessment for pharma firms
    Sable Bio
    11 Feb 2026

    Sable Bio secures a £2.7m seed round led by MMC Ventures to improve drug safety assessment for pharma firms

    Sable Bio builds AI tools to assess drug target safety in pharmaceutical research. Its platform analyses scientific data to identify potential toxicity risks earlier in development.

Sable Bio
  • Life Sciences
  • London, United Kingdom
  • £2.7m
  • sablebio.com
  • Update Information

More venture news

  • Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
    Imperagen
    21 May 2026

    Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering

    SeedLife Sciences
  • Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments
    Infex Therapeutic
    12 May 2026

    Infex Therapeutics secures £4.3m in funding led by Jon Moulton for antimicrobial resistance treatments

    EquityLife Sciences
  • Scarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases
    Scarlet Therapeutics
    11 May 2026

    Scarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases

    SeedLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn